<unk>  is an antiandrogen that is FDA approved for the treatment of metastatic castration-resistant prostate cancer.   Common adverse reactions include fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection and contusion.
Abiraterone
Indacaterol
Letrozole
Sermorelin
Conestat alfa
Ingenol mebutate
Ethylestrenol
Lynestrenol